Literature DB >> 28490504

Fasciculation in amyotrophic lateral sclerosis: origin and pathophysiological relevance.

Mamede de Carvalho1,2, Matthew C Kiernan3, Michael Swash2,4.   

Abstract

This review considers the origin and significance of fasciculations in neurological practice, with an emphasis on fasciculations in amyotrophic lateral sclerosis (ALS), and in benign fasciculation syndromes. Fasciculation represents a brief spontaneous contraction that affects a small number of muscle fibres, causing a flicker of movement under the skin. While an understanding of the role of fasciculation in ALS remains incomplete, fasciculations derive from ectopic activity generated in the motor system. A proximal origin seems likely to contribute to the generation of fasciculation in the early stages of ALS, while distal sites of origin become more prominent later in the disease, associated with distal motor axonal sprouting as part of the reinnervation response that develops secondary to loss of motor neurons. Fasciculations are distinct from the recurrent trains of axonal firing described in neuromyotonia. Fasciculation without weakness, muscle atrophy or increased tendon reflexes suggests a benign fasciculation syndrome, even when of sudden onset. Regardless of origin, fasciculations often present as the initial abnormality in ALS, an early harbinger of dysfunction and aberrant firing of motor neurons. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  amyotrophic lateral sclerosis; benign fasciculations; fasciculations; hyperexcitability; motor neuron disease

Mesh:

Year:  2017        PMID: 28490504     DOI: 10.1136/jnnp-2017-315574

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  17 in total

1.  Functional up-regulation of the M-current by retigabine contrasts hyperexcitability and excitotoxicity on rat hypoglossal motoneurons.

Authors:  Filippo Ghezzi; Laura Monni; Andrea Nistri
Journal:  J Physiol       Date:  2018-05-30       Impact factor: 5.182

2.  Fasciculation score: a sensitive biomarker in amyotrophic lateral sclerosis.

Authors:  Jing Ma; Qi Wen; Xiaomin Pang; Shan Huang; Jing Zhang; Juan Wang; Xueli Chang; Junhong Guo; Wei Zhang
Journal:  Neurol Sci       Date:  2021-03-11       Impact factor: 3.307

Review 3.  Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis.

Authors:  Stephen A Goutman; Orla Hardiman; Ammar Al-Chalabi; Adriano Chió; Masha G Savelieff; Matthew C Kiernan; Eva L Feldman
Journal:  Lancet Neurol       Date:  2022-03-22       Impact factor: 59.935

Review 4.  Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis.

Authors:  James J DiNicolantonio; James H O'Keefe; William Wilson
Journal:  Open Heart       Date:  2018-01-13

5.  Commentary: Amyotrophic Lateral Sclerosis and Myasthenia Gravis Overlap Syndrome: A Review of Two Cases and the Associated Literature.

Authors:  Ian Paul Johnson; Patrizia Longone
Journal:  Front Neurol       Date:  2017-07-27       Impact factor: 4.003

6.  Differentiating fasciculations from myoclonus in motor neuron disease.

Authors:  Susan Walker; Neil G Simon
Journal:  Clin Neurophysiol Pract       Date:  2017-12-20

7.  Clinical and research applications of neuromuscular ultrasound in amyotrophic lateral sclerosis.

Authors:  Stephanie L Barnes; Neil G Simon
Journal:  Degener Neurol Neuromuscul Dis       Date:  2019-07-16

8.  Count of Fasciculation in Ultrasound Can Predict the Prognosis of Amyotrophic Lateral Sclerosis.

Authors:  Hiroyuki Todo; Katsuya Nishida; Ryuki Ando; Hiroshi Yamasaki; Naonobu Futamura; Itaru Funakawa
Journal:  Ann Indian Acad Neurol       Date:  2019-10-25       Impact factor: 1.383

9.  Preprocessing surface EMG data removes voluntary muscle activity and enhances SPiQE fasciculation analysis.

Authors:  J Bashford; A Wickham; R Iniesta; E Drakakis; M Boutelle; K Mills; C E Shaw
Journal:  Clin Neurophysiol       Date:  2019-11-04       Impact factor: 3.708

Review 10.  ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?

Authors:  Rita Mejzini; Loren L Flynn; Ianthe L Pitout; Sue Fletcher; Steve D Wilton; P Anthony Akkari
Journal:  Front Neurosci       Date:  2019-12-06       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.